Just looking up to see when i first bought this share and started posting .
I knew it must be before October 2012.
I note nk 1999 asked if i was on it.... lol.
If that is year of his birth he would of only been 13 years old ??
He put lol but I'm the one laughing now.
My missus holds a load of GW & received 2 share certs from iii for her total holding (several K value in total) - well past any time to do ought about it as she was in hospital for cancer treatment. Now, she's left holding 2 paper certificates that she (or I) have little idea about how to go about trading on NASDAQ. Can anyone recommend a good broker I can open an account with & pass these to? Thanks in advance.
LONDON, Dec. 01, 2016 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ:GWPH) (AIM:GWP) ("GW," "the Company" or "the Group"), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announces results from two completed Epidiolex® (cannabidiol or CBD) Phase 3 trials, one in Lennox-Gastaut syndrome (LGS) and one in Dravet syndrome (DS), will be presented at the American Epilepsy Society (AES) Annual Meeting, December 2-6, 2016, in Houston, Texas.
More than a dozen independent reports from the State-sponsored Epidiolex Expanded Access Program, as well as additional laboratory studies of CBD, scientific updates, and an overview of the legal and regulatory climate for cannabinoids will also be presented during the meeting. For the first time, company-sponsored activities will be conducted under Greenwich Biosciences, Inc., GW's new name for its operating unit in the United States.
"We are very excited to share these data from our Phase 3 programs with the epilepsy community. These presentations are the culmination of intensive effort by the GW in-house team and more than 50 participating sites over the past two years, and reflect the courage and commitment of patients and their families. We can now focus on the ultimate goal, which is to gain approval for Epidiolex and make this much-needed treatment available," said Justin Gover, GW's Chief Executive Officer. "We have also reached an ideal moment to introduce our new U.S. identity, Greenwich Biosciences, which will be the face of our company to patients and their families, clinicians, and the general public in the United States."
Greenwich Biosciences (pronounced "gren-ich"), headquartered in Carlsbad, California, is incorporated in the United States and 100% owned by UK-based GW Pharmaceuticals plc. As the corporate parent, GW will remain the publicly-traded entity, be responsible for regulatory filings in the United States, and control the ongoing development and intellectual property associated with Epidiolex and the rest of the company's cannabinoid pipeline.
Results of Phase 3 Studies
Saturday, December 3; 12:00 6:00 PM CST/Poster Session
Cannabidiol (CBD) significantly reduces drop seizure frequency in Lennox-Gastaut syndrome: results of a multi-center, randomized, double-blind, placebo-controlled trial (GWPCARE4)
Sunday, December 4; 10:00 AM 4:00 PM CST/Poster Session
A dose ranging safety and pharmacokinetic study of cannabidiol (CBD) in children with Dravet syndrome (GWPCARE1)
Cannabidiol (CBD) reduces convulsive seizure frequency in Dravet syndrome: results of a multi-center, randomized, controlled trial (GWPCARE1)
Additional Laboratory Results
Saturday, December 3; 12:00 6:00 PM CST/Poster Session
The effect of a pharmaceutical formulation of pure cannabidiol on human CNS-expressed voltage-gated sodium channels
Expanded Access Program Presentations
Thirteen independent reports from the State-sponsored Expanded Access Program, including 11 posters from Alabama (two of which will also be given as oral presentations) and one each from Georgia and Idaho, covering varying aspects of the use of Epidiolex in children and adults, will be presented during sessions on Saturday, Sunday and Monday.
Scientific Exhibit Presentations
Monday, December 5
8:00 AM 11:00 AM CST, Room 330A, Convention Center Level 3
The company will host a satellite exhibit providing meeting attendees with a comprehensive overview of the Epidiolex development program, including the data presented in the AES poster sessions and the
following additional topics (authors will be on hand):
Cannabidiol does not convert to Δ9-tetrahydrocannabinol (THC) in an in vivo animal model
Epidiolex (cannabidiol) phase III data in treatment resistant epilepsy (encore to poster pre
Thought id put a cheeky limit buy in for same number at 7.20 @ 9.18 am
went strait through at 7.17p
Big buy 35 k just after @ 7.14 p
followed by several more at same price.
before 10 min break .. back to 7.25 p.
Could of sold on a couple of days last week for 896p .. Brokers and the like must love it .
I'm guessing the weakness is due to shorting and also UK people having to sell (with the brokers making the most of it). I've converted in my SIPP but sold from from ISA. Almost a nice forced taking of profits. It will be interesting to see what happens when the process is complete and they appear as ADR's in the SIPP.
Stop losses are all well and good but you can be taken out of a share as it dips and lose out as it rises again. As I noted don't get hung up on the short term ups and downs. You are either in for what you believe to be a long term ride or not.
Spread betting not for me .
The timing of all this .. with bank holiday USA thanksgiving ( yesterday ).. HALIFAX converted Monday others today .. all favors traders and of course the brokers.
Small investors trained to use stop losses ?
If you are dealing with a good broker you should be fine. HL have been clear on what is happening, the process is simple and free.
Swings in the share price don't bother me - I buy for the long term. There are sometimes opportunities to make a bit on the side spread betting. I ve done this with a few companies I own shares in - Regeneron, GWP, Goodwin. Where i get in and out making a grand here and there. Trick with the spreadbetting is to have a good amount of cash in the account to avoid being sold out automatically. It took me a good year to get my head around how to use that account.
Truth is GWPH...... up $1.79 today.
Nasdaq finished - 0.41%
GWP up and down 18% last week... brokers suggesting sells late on Friday ( As price dropped heavily )
Information on early conversion and non ISA "able" deliberately not clear and info delayed to clients. by smaller brokers.
Manipulation of share price needs looking at. city is full of untrustworthy types ... Beware.
Nasdaq getting hammered tonight, massive sell off here tomorrow IMHO
Bye bye GWP, all the best in the future state side
I'm out of here and well into PROX,
Made a shish load on GWP, thank you so much!
See you on another board x
Shorts reduced last week .
Brokers having a field day with this one last week.
one sent out an e-mail to clients late Friday pointing out high cost of dealing in USA and advising sell.
price then dropped about 5%.
Just visited my Hargreaves account. It was an easy tick box to have them transferred to ADR's. I have 3000 left of the 6000 I had originally so nicely divisable by 12. This has been a really good share and I think there is more to come.
This has been the biggest pain of a CA .. and i get a lot.
Early in week going to sell a few to round down ( 12 s )
have them i different acc's today rounded up in another for 839.1 ( just 38 ) lowest price so far .
But i never get lowest it so will drop below that before end.
I take it this discussion board will cease to be, once GWP's AIM listing stops. Would someone please confirm this? I've enjoyed the contributions, insight, and the ups and downs on here, so it will be a shame if we're no longer able to discuss.
Just returned from an extended holiday in OZ so new to all this discussion.
I am with Hargreaves Lansdown. They will transfer to ADR's free of charge. They will transfer my holding to their DTC account at HSBC and then to their HL CREST account. They say there 'may be a delay' before the ADR's will be tradeable but do not suggest how long. Trades are made in $ at the prevailing rate. Their standard deal costs apply (£11.95 for less than 10) but they then apply a spread currency charge of 1.5% for trades under £25k and 1.0% for trades under £50k. So in my case a few hundred £ to trade if I sold the entire holding.
I do not trade GWP so for me this is a toss up of the extra cost when I eventually sell vis what happens to the share price in the meantime. I take the view that there is considerable upside opportunity which will make the trading costs of minor importance. I do not anticipate needing to trade in the short to medium term. Of course I may be completely wrong and regret the decision but I plan to transfer to ADR's accepting the fact that it is not cost effective to trade on a regular basis.
Important message from the Financial Conduct Authority:
Posting inside information that is not public knowledge, or information that is false or misleading, may constitute market abuse.
This could lead to an unlimited fine and up to seven years in prison.
If you have any information, concerns or queries about market abuse, click here.
The content of the messages posted represents the opinions of the author, and does not represent the opinions of Interactive Investor Trading Limited or its affiliates and has not been approved or issued by Interactive Investor Trading Limited.
You should be aware that the other participants of the above discussion group are strangers to you and may make statements which may be misleading, deceptive or wrong.
Please remember that the value of investments or income from them may go down as well as up and that the past performance of an investment is not a guide to its performance in the future.
The discussion boards on this site are intended to be an information sharing forum and is not intended to address your particular requirements.
Whilst information provided on them can help with your investment research you need to consider carefully whether you should make (or refraining from making) investment or other decisions based on what you see without doing further research on investments you are interested in.
Participating in this forum cannot be a substitute for obtaining advice from an appropriate expert independent adviser who takes into account your circumstances and specific investment needs in selected investments that are appropriate for you.